BCAL Diagnostics Limited (ASX:BDX)

BCAL Diagnostics Statistics

Total Valuation

ASX:BDX has a market cap or net worth of AUD 44.17 million. The enterprise value is 44.28 million.

Market Cap	44.17M
Enterprise Value	44.28M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

ASX:BDX has 368.07 million shares outstanding. The number of shares has increased by 14.40% in one year.

Current Share Class	368.07M
Shares Outstanding	368.07M
Shares Change (YoY)	+14.40%
Shares Change (QoQ)	+3.93%
Owned by Insiders (%)	29.31%
Owned by Institutions (%)	6.36%
Float	177.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.40
PB Ratio	17.68
P/TBV Ratio	17.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.18
EV / Sales	17.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.86

Financial Position

The company has a current ratio of 3.67, with a Debt / Equity ratio of 1.38.

Current Ratio	3.67
Quick Ratio	3.67
Debt / Equity	1.38
Debt / EBITDA	n/a
Debt / FCF	-0.53
Interest Coverage	-45.98

Financial Efficiency

Return on equity (ROE) is -121.67% and return on invested capital (ROIC) is -52.37%.

Return on Equity (ROE)	-121.67%
Return on Assets (ROA)	-46.59%
Return on Invested Capital (ROIC)	-52.37%
Return on Capital Employed (ROCE)	-117.84%
Weighted Average Cost of Capital (WACC)	7.82%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.27
Inventory Turnover	n/a

Taxes

In the past 12 months, ASX:BDX has paid 21,299 in taxes.

Income Tax	21,299
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.09% in the last 52 weeks. The beta is 0.71, so ASX:BDX's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	+9.09%
50-Day Moving Average	0.12
200-Day Moving Average	0.08
Relative Strength Index (RSI)	52.20
Average Volume (20 Days)	145,519

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:BDX had revenue of AUD 2.54 million and -7.16 million in losses. Loss per share was -0.02.

Revenue	2.54M
Gross Profit	2.54M
Operating Income	-6.92M
Pretax Income	-7.14M
Net Income	-7.16M
EBITDA	-6.41M
EBIT	-6.92M
Loss Per Share	-0.02

Balance Sheet

The company has 3.33 million in cash and 3.44 million in debt, with a net cash position of -109,110 or -0.00 per share.

Cash & Cash Equivalents	3.33M
Total Debt	3.44M
Net Cash	-109,110
Net Cash Per Share	-0.00
Equity (Book Value)	2.50M
Book Value Per Share	0.01
Working Capital	3.48M

Cash Flow

In the last 12 months, operating cash flow was -5.96 million and capital expenditures -498,180, giving a free cash flow of -6.46 million.

Operating Cash Flow	-5.96M
Capital Expenditures	-498,180
Free Cash Flow	-6.46M
FCF Per Share	-0.02

Margins

Gross margin is 100.00%, with operating and profit margins of -272.60% and -282.10%.

Gross Margin	100.00%
Operating Margin	-272.60%
Pretax Margin	-281.26%
Profit Margin	-282.10%
EBITDA Margin	-252.66%
EBIT Margin	-272.60%
FCF Margin	n/a

Dividends & Yields

ASX:BDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.40%
Shareholder Yield	-14.40%
Earnings Yield	-16.21%
FCF Yield	-14.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:BDX has an Altman Z-Score of -4.58 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.58
Piotroski F-Score	3